Awareness

Dr. Boada, recognized with the Fenin Award for Healthcare Technological Innovation

24/11/2022
Dr. Mercè Boada has been awarded the Fenin Award for Healthcare Technological Innovation, for her contribution as well as her scientific and social leadership in the field of Alzheimer's disease.

Ace Alzheimer Center Barcelona; new member of NANOMED Spain

30/11/2022Research
The Coordinating Committee of NANOMED Spain, an organization of reference in Spain in nanomedicine studies, has accepted the membership application of Ace Alzheimer Center Barcelona, which becomes part of the platform as a research center.

Blog | What happens if you lose the Y chromosome?

22/11/2022Research
The loss of the Y chromosome (mLOY) is common among men older than 65 years and is associated with an increased risk of Alzheimer's as well as a faster progression of the disease.

A new drug for Alzheimer's could reach the market in 2023

28/09/2022Research
The pharmaceutical companies Eisai and Biogen have just announced to the press the results of their monoclonal antibody Lecanemab, a drug targeted at the deposit of amyloid in the brain.

Dr. Montse Alegret presents the results of Facememory® at the meeting of the International Neuropsychological Society

11/07/2022Research
Ace Alzheimer Center Barcelona had a prominent presence with the presentation of the results of the administration of Facememory®, the tool for early detection of cognitive impairment, administered in our BIOFACE cohort

Five professionals of Ace in the Top 5,000 female researchers ranking

13/06/2022Research
The Higher Council for Scientific Research (CSIC) publishes the ranking of Spanish and foreign female researchers in Spain with the aim of increasing the visibility of the country's researchers and their work.